Cefabactin vet.

25 x 10 pc
Tablet
PO

Species

Dogs and cats.

Indications

For the treatment of:

- Respiratory tract infections, especially bronchopneumonia, caused by Staphylococcus aureus, Streptococcus spp., Escherichia coli and Klebsiella spp.

- Urinary tract infections caused by Escherichia coli, Proteus spp. and Staphylococcus spp.

- Skin infections in cats caused by Staphylococcus spp. and Streptococcus spp. and skin infections in dogs caused by Staphylococcus spp.

Dose to be administered and administration route

For oral administration.

The recommended dose is 15-30 mg cefalexin per kg body weight twice a day, during at least 5 consecutive days. An extended course of treatment may be prescribed by the responsible veterinarian in cases of, for example, urinary tract infections or bacterial dermatitis.

To ensure a correct dosage body weight should be determined as accurately as possible to avoid underdosing.

The following table is intended as a guide to dispensing the product at a dose rate of 15 mg cefalexine per kg body weight twice a day.

ADMINISTRATION TWICE DAILY

     

Body weight

Dose

mg

Cefabactin 50 mg

Cefabactin 250 mg

Cefabactin 500 mg

Cefabactin 1000 mg

>0.5 kg – 0.8 kg

12.5

-

-

-

>0.8 kg – 1.6 kg

25

-

-

-

>1.6 kg – 2.5 kg

37.5

-

-

-

>2.5 kg – 3.3 kg

50

-

-

-

>3.3 kg – 5 kg

75

-

-

-

>5 kg – 6.6 kg

100

-

-

-

>6.6 kg – 8 kg

125

image

-

-

>8 kg – 10 kg

150

-

-

-

>10 kg – 12.5 kg

188

-

-

-

>12.5 kg – 16.6 kg

250

-

image

-

>16.6 kg – 20 kg

313

 

 

 

>20 kg – 25 kg

375

-

-

-

>25 kg – 29 kg

438

-

-

-

>29 kg – 33 kg

500

-

image

>33 kg – 41 kg

625

-

-

-

>41 kg – 50 kg

750

-

-

image

>50 kg – 58 kg

875

-

-

-

>58 kg – 66 kg

1000

-

-

>66 kg – 83kg

1250

-

-

-

image= ¼ Tablet = ½ Tablet image= ¾ Tablet image= 1 Tablet

Tablets can be divided into 2 or 4 equal parts to ensure accurate dosing. Place the tablet on a flat surface with its scored side facing up.

image

Halves: press down with your thumbs on both sides of the tablet.

Quarters: press down with your thumb in the middle of the tablet.

Adverse reactions

Mild and transient vomiting and diarrhoea have been observed very commonly in cats even at the lowest recommended dosage regime. The symptoms were reversible in most cats without symptomatic treatment. Vomiting has been observed occasionally in dogs treated with products containing cefalexin. As with other antibiotics, diarrhoea can occur. In case of recurring vomiting and/or diarrhoea, the treatment should be discontinued and the advice of the attending veterinarian sought.

Lethargy can occur very rarely.

Hypersensitivity can occur rarely. In cases of hypersensitivity reactions the treatment should be discontinued.

 

The frequency of adverse reactions is defined using the following convention:

- very common (more than 1 in 10 animals treated displaying adverse reaction(s))

- common (more than 1 but less than 10 animals in 100 animals treated)

- uncommon (more than 1 but less than 10 animals in 1,000 animals treated)

- rare (more than 1 but less than 10 animals in 10,000 animals treated)

- very rare (less than 1 animal in 10,000 animals treated, including isolated reports)

Dispensing

POM-V

EMA Categorisation

C
Cat
Dog
PRICE Only for registered vets. Create a free profile to access all features.. Login
Art. Nr. 41821/5015
EAN 8717973561897
PACKAGES
Cefabactin vet.
Dechra Veterinary Products
25 x 10 pc
41821/5015

Similar products

Showing 1 of 1 results
Only for registered vets. Create a free profile to access all features. Login
Cat
Dog

Cefabactin vet.

50 mg Tablet
25 x 10 pc
VETiSearch ApS - C.F. Richs Vej 99D - 2000 Copenhagen - Denmark - contact@vetisearch.co.uk - Legal registration number: 39926679
VETiSearch.co.uk Copyright © 2025 . All rights reserved. This information is intended only for residents of Great Britain. The product information provided on this site is intended only for residents of Great Britain. Products may have different product information in different countries.